Recent findings have implicated the process of EMT in mediating the functional conversion of TGF-β during breast cancer progression, suggesting that the chemotherapeutic targeting of EMT induced by TGF-β may offer new approaches in ameliorating metastatic disease [159, 168]. Here, TGFB1 is linked to metastatic neoplasm.